BLANDIZZI, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 1.317
AS - Asia 1.269
EU - Europa 763
SA - Sud America 106
OC - Oceania 24
AF - Africa 23
Totale 3.502
Nazione #
US - Stati Uniti d'America 1.293
RU - Federazione Russa 448
CN - Cina 406
SG - Singapore 365
IT - Italia 149
KR - Corea 129
HK - Hong Kong 125
VN - Vietnam 83
BR - Brasile 76
IN - India 48
PL - Polonia 46
JP - Giappone 36
BD - Bangladesh 35
FR - Francia 31
AU - Australia 24
IE - Irlanda 22
DE - Germania 19
AR - Argentina 13
CA - Canada 12
SE - Svezia 12
FI - Finlandia 11
GB - Regno Unito 11
ES - Italia 7
ID - Indonesia 7
IQ - Iraq 7
MX - Messico 7
NG - Nigeria 7
VE - Venezuela 5
CI - Costa d'Avorio 4
CO - Colombia 4
ZA - Sudafrica 4
JO - Giordania 3
PE - Perù 3
PR - Porto Rico 3
TR - Turchia 3
BJ - Benin 2
EC - Ecuador 2
IR - Iran 2
KE - Kenya 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NL - Olanda 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.502
Città #
Santa Clara 575
Singapore 269
Ashburn 217
Hefei 179
Seoul 126
Hong Kong 121
San Jose 70
Warsaw 46
The Dalles 38
Milan 35
Moscow 35
Tokyo 35
Beijing 30
Ho Chi Minh City 24
Mumbai 24
Shanghai 23
Dublin 22
Fairfield 21
Los Angeles 20
Lauterbourg 19
Melbourne 19
Rome 19
Chandler 18
Kent 17
New York 16
Buffalo 15
Hanoi 15
West Jordan 14
Florence 13
Bengaluru 11
Council Bluffs 11
Cambridge 10
Wilmington 10
Woodbridge 9
Houston 8
Helsinki 7
Munich 7
Paris 7
Seattle 7
São Paulo 7
Abuja 6
Chennai 6
Jakarta 6
Altamura 5
Dallas 5
Frankfurt am Main 5
Lawrence 5
Manchester 5
Naples 5
San Francisco 5
Sydney 5
Abidjan 4
Baghdad 4
Boardman 4
Boston 4
Chicago 4
Dong Ket 4
Haiphong 4
London 4
Miano 4
Princeton 4
Barcelona 3
Bhubaneswar 3
Biên Hòa 3
Buenos Aires 3
Da Nang 3
Denver 3
Genoa 3
Isidro Casanova 3
Mexico City 3
Palermo 3
Tianjin 3
Atlanta 2
Bari 2
Belo Horizonte 2
Bogotá 2
Bologna 2
Catania 2
Caxias do Sul 2
Chalco 2
Cincinnati 2
Clifton 2
Cotonou 2
Curitiba 2
Dhaka 2
Enid 2
Fortaleza 2
Franca 2
Jacksonville 2
Johannesburg 2
Lappeenranta 2
Lima 2
Memphis 2
Nairobi 2
Nuremberg 2
Orem 2
Padua 2
Phoenix 2
Ribeirão Preto 2
Riyadh 2
Totale 2.356
Nome #
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 197
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope 197
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 194
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 175
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 167
Hepatitis C virus infection: opportunities for an earlier detection in primary care 160
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 156
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 149
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 146
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 145
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 145
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 139
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 137
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 136
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 134
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 133
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 133
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 133
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 131
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 131
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 129
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 126
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 121
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 118
Totale 3.532
Categoria #
all - tutte 9.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 1 0 0 2 1 1 0 2 1 4 3 6
2022/202382 7 12 4 9 8 12 10 11 7 1 1 0
2023/2024183 0 5 3 23 4 7 4 62 6 36 5 28
2024/20251.406 39 137 82 173 408 264 6 64 57 25 67 84
2025/20261.688 206 268 249 122 159 51 180 86 70 106 29 162
2026/202726 26 0 0 0 0 0 0 0 0 0 0 0
Totale 3.532